Others

Bal Pharma Ltd. - Announcement under Regulation 30 (LODR)-Meeting Updates

| Updated on September 22, 2018 Published on September 22, 2018

we are submitting to the exchange the business transacted at the 31th Annual General Meeting of the Company held on 22.09.2018, at Bharatiya Vidya Bhavan, Race Course Road, Bangalore.
The Meeting commenced at 11.00 AM and concluded at 12.30 PM.
Ordinary Business:
1. Adopted the audited financial statements of the Company for the financial year ended 31.3.2018, together with Boards report and Independent Auditors Report.
2. Declared a dividend of Re.1/- per equity share of Rs.10/- each (i.e 10%), for the financial year ended 31.3.2018.
3. Ratified the appointment of NSVM & Associates, Chartered accountants as Statutory Auditors of the Company.
Special Business:
4. Approved to increase in investments limits of NRIs and FPIs in the share capital of the Company to 24% and 50% respectively.
5. Approved reappointment of Dr.Subba Rao Prasanna as Whole time Director of the Company for a tenure of 2 (two) years.
6. Ratified the remuneration payable to the Cost Auditors of the Company.




Pdf Link: Bal Pharma Ltd. - Announcement under Regulation 30 (LODR)-Meeting Updates

Source : BSE - www.bseindia.com

Published on September 22, 2018
This article is closed for comments.
Please Email the Editor